Form 8-K - Current report:
SEC Accession No. 0001628280-25-001244
Filing Date
2025-01-13
Accepted
2025-01-13 08:01:07
Documents
52
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prme-20250113.htm   iXBRL 8-K 26802
2 EX-99.1 jan_2025xcorpxpresentati.htm EX-99.1 46935
6 jan_2025xcorpxpresentati001.jpg GRAPHIC 63164
7 jan_2025xcorpxpresentati002.jpg GRAPHIC 313346
8 jan_2025xcorpxpresentati003.jpg GRAPHIC 113357
9 jan_2025xcorpxpresentati004.jpg GRAPHIC 113469
10 jan_2025xcorpxpresentati005.jpg GRAPHIC 150399
11 jan_2025xcorpxpresentati006.jpg GRAPHIC 148991
12 jan_2025xcorpxpresentati007.jpg GRAPHIC 120185
13 jan_2025xcorpxpresentati008.jpg GRAPHIC 134300
14 jan_2025xcorpxpresentati009.jpg GRAPHIC 105877
15 jan_2025xcorpxpresentati010.jpg GRAPHIC 81045
16 jan_2025xcorpxpresentati011.jpg GRAPHIC 117909
17 jan_2025xcorpxpresentati012.jpg GRAPHIC 54127
18 jan_2025xcorpxpresentati013.jpg GRAPHIC 58923
19 jan_2025xcorpxpresentati014.jpg GRAPHIC 134031
20 jan_2025xcorpxpresentati015.jpg GRAPHIC 114177
21 jan_2025xcorpxpresentati016.jpg GRAPHIC 139735
22 jan_2025xcorpxpresentati017.jpg GRAPHIC 81608
23 jan_2025xcorpxpresentati018.jpg GRAPHIC 100618
24 jan_2025xcorpxpresentati019.jpg GRAPHIC 52628
25 jan_2025xcorpxpresentati020.jpg GRAPHIC 150358
26 jan_2025xcorpxpresentati021.jpg GRAPHIC 144980
27 jan_2025xcorpxpresentati022.jpg GRAPHIC 106725
28 jan_2025xcorpxpresentati023.jpg GRAPHIC 42957
29 jan_2025xcorpxpresentati024.jpg GRAPHIC 126420
30 jan_2025xcorpxpresentati025.jpg GRAPHIC 104006
31 jan_2025xcorpxpresentati026.jpg GRAPHIC 137700
32 jan_2025xcorpxpresentati027.jpg GRAPHIC 148440
33 jan_2025xcorpxpresentati028.jpg GRAPHIC 40093
34 jan_2025xcorpxpresentati029.jpg GRAPHIC 134325
35 jan_2025xcorpxpresentati030.jpg GRAPHIC 122097
36 jan_2025xcorpxpresentati031.jpg GRAPHIC 120745
37 jan_2025xcorpxpresentati032.jpg GRAPHIC 45815
38 jan_2025xcorpxpresentati033.jpg GRAPHIC 126826
39 jan_2025xcorpxpresentati034.jpg GRAPHIC 164900
40 jan_2025xcorpxpresentati035.jpg GRAPHIC 171197
41 jan_2025xcorpxpresentati036.jpg GRAPHIC 45799
42 jan_2025xcorpxpresentati037.jpg GRAPHIC 99283
43 jan_2025xcorpxpresentati038.jpg GRAPHIC 126736
  Complete submission text file 0001628280-25-001244.txt   6224703

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20250113.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20250113_lab.xml EX-101.LAB 22531
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20250113_pre.xml EX-101.PRE 13055
54 EXTRACTED XBRL INSTANCE DOCUMENT prme-20250113_htm.xml XML 2913
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 25524879
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)